Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells

Yonghua Shi(Xinjiang Medical University), Hong Zhang(Memorial Sloan Kettering Cancer Center)
Oncotarget
September 15, 2016
Cited by 31


Related Papers